TRIESTE, LEOPOLDO Statistiche

TRIESTE, LEOPOLDO  

DIPARTIMENTO DI FARMACIA  

Mostra records
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 1-gen-2023 Convertino, I.; Cazzato, M.; Tillati, S.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Bonaso, M.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M.
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 1-gen-2021 Giometto, S; Convertino, I; Tuccori, M; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Turchetti, G; Trieste, L; Lorenzoni, V; Blandizzi, C; Mosca, M; Lucenteforte, E
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 1-gen-2021 Convertino, I.; Giometto, S.; Gini, R.; Cazzato, M.; Fornili, M.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Bartolini, C.; Paoletti, O.; Tillati, S.; Baglietto, L.; Turchetti, G.; Trieste, L.; Lorenzoni, V.; Blandizzi, C.; Mosca, M.; Tuccori, M.; Lucenteforte, E.
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 1-gen-2021 Convertino, Irma; Lucenteforte, Ersilia; Gini, Rosa; Lorenzoni, Valentina; Cazzato, Massimiliano; Turchetti, Giuseppe; Trieste, Leopoldo; Ferraro, Sara; Leonardi, Luca; Roberto, Giuseppe; Luciano, Nicoletta; Blandizzi, Corrado; Mosca, Marta; Tuccori, Marco
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 1-gen-2021 Convertino, I.; Cazzato, M.; Giometto, S.; Gini, R.; Valdiserra, G.; Cappello, E.; Ferraro, S.; Tillati, S.; Bartolini, C.; Paoletti, O.; Lorenzoni, V.; Trieste, L.; Filippi, M.; Turchetti, G.; Cristofano, M.; Blandizzi, C.; Mosca, M.; Lucenteforte, E.; Tuccori, M.
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 1-gen-2021 Convertino, I; Cazzato, M; Giometto, S; Gini, R; Lucenteforte, E; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Lorenzoni, V; Trieste, L; Filippi, M; Turchetti, G; Cristofano, M; Blandizzi, C; Mosca, M; Tuccori, M
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 1-gen-2020 Convertino, I; Giometto, S; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Fornili, M; Turchetti, G; Lorenzoni, V; Trieste, L; Mosca, M; Blandizzi, C; Tuccori, M; Lucenteforte, E
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 1-gen-2019 Convertino, I; Lucenteforte, E; Lorenzoni, V; Turchetti, G; Trieste, L; Roberto, G; Cazzato, M; Mosca, M; Ferraro, S; Leonardi, L; Luciano, N; Gini, R; Blandizzi, C; Tuccori, M
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 1-gen-2019 Convertino, I; Tuccori, M; Lucenteforte, E; Mosca, M; Turchetti, G; Lorenzoni, V; Trieste, L; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 1-gen-2019 Lorenzoni, V; Trieste, L; Mosca, M; Convertino, I; Tuccori, M; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R; Turchetti, G